Stockreport

Ocular Therapeutix, Inc. (OCUL) Discusses Positive Top Line Results From SOL-1 Phase 3 Trial of AXPAXLI in Wet AMD Transcript [Seeking Alpha]

Ocular Therapeutix, Inc.  (OCUL) 
Last ocular therapeutix, inc. earnings: 3/12 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ocutx.com
PDF Company Participants William Slattery - Vice President of Investor Relations Pravin Dugel - Executive Chairman, President & CEO Conference Call Participants Ars [Read more]